Mesoblast (MESO) Tax Provisions (2016 - 2023)
Mesoblast recorded quarterly Tax Provisions of -$384000.0 in Q2 2023, down 934.78% quarter-over-quarter from $46000.0 in Q1 2023, and up 9.86% year-over-year from -$349538.5 in Q2 2022.
Mesoblast's Tax Provisions history runs 8 years deep, the most recent figure standing at -$384000.0 for Q2 2023.
- In Q2 2023, Tax Provisions rose 9.86% year-over-year to -$384000.0; the TTM figure through Jun 2023 stood at -$212000.0 (up 11.3% YoY), while the FY2025 annual figure was $330000.0, up 272.77% from the prior year.
- Tax Provisions came in at -$384000.0 for Q2 2023 at Mesoblast, down from $46000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $3.2 million in Q2 2019 to a low of -$15.6 million in Q2 2020.
- A 5-year average of -$294722.2 and a median of $66500.0 in 2021 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions surged 211.17% in 2019 and slumped 590.18% in 2020, its largest moves.
- Mesoblast's Tax Provisions stood at $2.3 million in 2019, then slumped by 103.26% to -$74000.0 in 2020, then jumped by 208.11% to $80000.0 in 2021, then dropped by 11.25% to $71000.0 in 2022, then slumped by 640.85% to -$384000.0 in 2023.
- According to Business Quant data, Tax Provisions over the past three periods registered -$384000.0, $46000.0, and $71000.0 for Q2 2023, Q1 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Mesoblast | 23.40 Bn | 23.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -384,000.00 |
| Mar 31, 2023 | 46,000.00 |
| Dec 31, 2022 | 71,000.00 |
| Sep 30, 2022 | 55,000.00 |
| Jun 30, 2022 | -426,000.00 |
| Mar 31, 2022 | 45,000.00 |
| Dec 31, 2021 | 80,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Jun 30, 2021 | -1.57 Mn |
| Mar 31, 2021 | 98,000.00 |
| Dec 31, 2020 | -74,000.00 |
| Sep 30, 2020 | 730,000.00 |
| Jun 30, 2020 | -15.57 Mn |
| Mar 31, 2020 | 1.96 Mn |
| Dec 31, 2019 | 2.27 Mn |
| Sep 30, 2019 | 1.93 Mn |
| Jun 30, 2019 | 3.18 Mn |
| Mar 31, 2019 | 2.21 Mn |
| Dec 31, 2018 | 2.87 Mn |
| Sep 30, 2018 | 711,000.00 |
| Jun 30, 2018 | 1.02 Mn |
| Mar 31, 2018 | 3.43 Mn |
| Dec 31, 2017 | 23.34 Mn |
| Sep 30, 2017 | 2.90 Mn |
| Jun 30, 2017 | 4.08 Mn |
| Mar 31, 2017 | 3.09 Mn |
| Dec 31, 2016 | 3.13 Mn |
| Sep 30, 2016 | 3.11 Mn |
| Jun 30, 2016 | 82.50 Mn |